John Kaweske is the President of Bio Clean Energy, S.A. a holding company with diversified assets in the clean energy sector. He has decades of experience in the biotechnology sector. He spent nearly 20 years as a Managing Director within investment banking firms, specifically focusing on reviewing startup companies within biotech for potential investment. He has participated on the Board of Directors of several companies and closed a number of lucrative M&A transactions.
Clean Energy, Bioenergy and biodiesel
Jennifer A Littlechild is a Professor of Biological Chemistry and has established the Henry Wellcome Centre for Biocatalysis at Exeter University in 2003. Her research studies involve the structural and mechanistic characterization of a range of enzymes from thermophilic bacteria and archaea that have industrial applications. She has a particular interest in thermophilic carbonic anhydrase enzymes and has carried out a project with Statoil from 2011-2013. She has published over 200 publications in high impact journals and has presented her research work internationally. She is the UK Representative and Vice-Chair of the European Section of Applied Biocatalysis and member of EU Advisory Committee for Industrial Biotechnology
Dr Sergey Suchkov, MD, PhD. Professor in Immunology & Medicine. Personal: Born 11 January 1957, Astrakhan, Russia. divorced; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, 1985; Doctor Degree, National Institute of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Institute of Medical Enzymology, 1985-87; Senior Research Associate, Koltzov Institute of Developmental Biology, USSR Academy of Sciences, 1987-89; Head of the Lab of Immunology and Immunobiotechnology, Helmholtz Eye Research Institute in Moscow, 1989-95; Trainee, Laboratory of Immunology, NEI, Bethesda, MD, USA, NIH and Laboratory of Immunology, Wills Eye Hospital, Philadelphia, USA, as well as at some of the British Universities on the invitation of the Royal Society for Immunology, 1989; Chairman, Department for Clinical Immunology, Moscow Clinical Research Institute and the Immunologist-in-Chief of the Moscow Regional Ministry of Health, 1995-2004; Executive Secretary-in-Chief of the Editorial Board, Biomedical Science International journal, 1993-1996; Professor in Medicine and Immunology, I.M. Sechenov First Moscow Medical University and Faculty Chairman & Director of the Department of Preventive, Personalized and Translational Medicine, A.I.Evdokimov Moscow State University of Medicine & Dentistry. Honours: Secretary General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; European Association for Predictive, Preventive and Personalized Medicine, Brussels; American Association for Research in Vision and Ophthalmology; International Society for Eye Research; EPMA Journal, Personalized Medicine Universe, Open J.Autoimmunity and American J.Cardiovascular Res. Editorial Boards; All-Union (from 1992 - Russian) Biochemical Society; All-Union (from 1992 - Russian) Immunological Society.
Scientific and Clinical collaboration in the field of ocular immunology between Russian Academy of Sciences and National Institute of Health(NIH)
Wee Sim Choo completed a Bachelor of Science in Food Studies (2001) majoring in Food Quality Management and Master of Science (2004) in the field of Food Chemistry and Biochemistry from University Putra Malaysia. She then joined the Malaysian Palm Oil Board as a research officer before moving to the University of Otago, New Zealand to complete a Ph.D. in Food Science in 2008. She won the Honored Student Award from the American Oil Chemists’ Society in May 2008. She joined Monash University Malaysia soon after and is currently a Senior Lecturer for the School of Science. In 2013 she obtained a Graduate Certificate in Higher Education from Monash University Malaysia, and as a result of her engaging teaching style, she has been awarded three PVC’s Awards for Excellence in Teaching. She has published 1 book, 2 book chapters, 1 encyclopedia chapter, and over 30 ISI-journal papers.
As Marketing & Communications Manager at IBioIC, Ashley’s role is to maximize the impact of its industrial members and academic partners activities and to demonstrate the work that is being achieved in the IB industry throughout Scotland. Ashley is also the curator of IBioIC’s Annual Conference, the largest IB conference in the UK which showcases the latest research and technological developments to an audience of over 450 delegates. The Industrial Biotechnology Innovation Centre (IBioIC)’s role as a specialist in the Industrial Biotechnology (IB) sector, is to stimulate the growth of the IB sector in Scotland to £900 million by 2025. IBioIC connects industry, academia, and government and facilitates collaborations, provides scale-up capabilities, creates networks and develops skills.
Biobased products, New IB Tools & Technologies
Prof. Ir. Dr. Ani Idris, is a Professor in the Department of Bioprocess and Polymer Engineering, Faculty of Chemical and Energy Engineering at Universiti Teknologi Malaysia and also holds a cross-appointment as a Fellow in Institute of Bioproduct Development. She is also a founder of MEMTEC PLT a spinoff company of Universiti Teknologi Malaysia. She was awarded as Malaysia Top Research Scientist in 2015. She is a Chartered Chemical Engineer and also a Professional Engineer. She has published more than 140 impact factor journals relating to her research area, obtained over 2253 citations, H- index 26 and has 6 patents granted.
Membrane technology involves: making of reverse osmosis, dialysis and ultrafiltration membranes, Converting agricultural waste to higher value added products, Microalgae cultivation and bioprocessing into biodiesel